Prostate Specific Antigen Velocity in Men With Total Prostate Specific Antigen Less Than 4 ng/ml

Journal of Urology

Volumn 178, Issue 6, 2007, Pages 2348-2353

  Loeb, Stacy ^a   Roehl, Kimberly A ^b   Nadler, Robert B ^c   Yu, Xiaoying ^c   Catalona, William J ^c  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

mass screening; prostate specific antigen; prostatic neoplasms

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGE; AGED; ANTIGEN DETECTION; ARTICLE; CALCULATION; CANCER SCREENING; DIAGNOSTIC VALUE; FAMILY HISTORY; HUMAN; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL ANALYSIS; MULTIVARIATE ANALYSIS; PERFORMANCE; PREDICTION; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE SPECIFIC ANTIGEN VELOCITY; RACE; SCREENING TEST; UNIVARIATE ANALYSIS;

AGE DISTRIBUTION; AGED; BIOPSY, NEEDLE; COHORT STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; INCIDENCE; MALE; MASS SCREENING; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; RISK ASSESSMENT; ROC CURVE; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS;

EID: 35748984087     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2007.08.016     Document Type: Article

References (16)

1. Carter H.B., Pearson J.D., Metter E.J., Brant L.J., Chan D.W., Andres R., et al. Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease. JAMA 267 (1992) 2215
2. Smith D.S., and Catalona W.J. Rate of change in serum prostate specific antigen levels as a method for prostate cancer detection. J Urol 152 (1994) 1163
3. D'Amico A.V., Chen M.H., Roehl K.A., and Catalona W.J. Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy. N Engl J Med 351 (2004) 125
4. D'Amico A.V., Renshaw A.A., Sussman B., and Chen M.H. Pretreatment PSA velocity and risk of death from prostate cancer following external beam radiation therapy. JAMA 294 (2005) 440
5. Eggener S.E., Roehl K.A., Yossepowitch O., and Catalona W.J. Prediagnosis prostate specific antigen velocity is associated with risk of prostate cancer progression following brachytherapy and external beam radiation therapy. J Urol 176 (2006) 1399
6. Patel D.A., Presti Jr. J.C., McNeal J.E., Gill H., Brooks J.D., and King C.R. Preoperative PSA velocity is an independent prognostic factor for relapse after radical prostatectomy. J Clin Oncol 23 (2005) 6157
7. Loeb S., Roehl K.A., Antenor J.A., Catalona W.J., Suarez B.K., and Nadler R.B. Baseline prostate-specific antigen compared with median prostate-specific antigen for age group as predictor of prostate cancer risk in men younger than 60 years old. Urology 67 (2006) 316
8. Loeb S., Roehl K.A., Catalona W.J., and Nadler R.B. Prostate specific antigen velocity threshold for predicting prostate cancer in young men. J Urol 177 (2007) 899
9. Moul J.W., Sun L., Hotaling J.M., Fitzsimons N.J., Polascik T.J., Robertson C.N., et al. Age adjusted prostate specific antigen and prostate specific antigen velocity cut points in prostate cancer screening. J Urol 177 (2007) 499
10. Yu X., Loeb S., Roehl K.A., Han M., and Catalona W.J. The association between total prostate specific antigen concentration and prostate specific antigen velocity. J Urol 177 (2007) 1298
11. Smith D.S., and Catalona W.J. The nature of prostate cancer detected through prostate specific antigen based screening. J Urol 152 (1994) 1732
12. Carter H.B., Ferrucci L., Kettermann A., Landis P., Wright E.J., Epstein J.I., et al. Detection of life-threatening prostate cancer with prostate-specific antigen velocity during a window of curability. J Natl Cancer Inst 98 (2006) 1521
13. Fang J., Metter E.J., Landis P., Chan D.W., Morrell C.H., and Carter H.B. Low levels of prostate-specific antigen predict long-term risk of prostate cancer: results from the Baltimore Longitudinal Study of Aging. Urology 58 (2001) 411
14. Djavan B., Zlotta A., Remzi M., Ghawidel K., Basharkhah A., Schulman C.C., et al. Optimal predictors of prostate cancer on repeat prostate biopsy: a prospective study of 1,051 men. J Urol 163 (2000) 1144
15. National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology: Prostate Cancer Early Detection. http://www.nccn.org/professionals/physician_gls/PDF/prostate_detection.pdf. Accessed December 17, 2006.
16. Thompson I.M., Pauler D.K., Goodman P.J., Tangen C.M., Lucia M.S., Parnes H.L., et al. Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter. N Engl J Med 350 (2004) 2239